Secondary immunodeficiency
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Physicians in hematology, general internal medicine and infectious diseases departments who practice hematological diseases
Exclusion criteria
Exclusion criteria: ?Physicians who have less than 3 years of practice excluding training period ?Physicians who work in a facility other than clinics, university hospitals, national and public hospitals, or public medical institutions/private hospitals ?Physicians who currently treating zero/none outpatients and inpatients ?Physicians who are related to Takeda and/or the Contract Research Organizations (CROs)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The level of disease awareness and perspective of SID practice.(At the time of web survey) | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment options, clinical evaluation, diagnosis, standard of care and management flow of SID. (At the time of web survey) | — |
Countries
Japan
Contacts
Takeda Pharmaceutical Company Limited Japan Medial Office